semaglutide oral fda approval approves for type 2 diabetes, obesity indication pending | MedCentral posted on the topic FDA Sets Action Date for

SKU: 25129615702

Pay in 4 interest-free payments of $6.50 Learn more

Live Spec

FDA Sets Action Date for Oral Wegovy for Weight Loss Managed Healthcare Executive FDA Approves Oral Semaglutide for Weight Loss Oral Wegovy approved for obesity management by FDA on December 23, 2025 Formulation: Highdose oral semaglutide (25 mg daily) previously only available as weekly injections. Indication: Adults with obesity (BMI 30) Wegovy Pill Gets FDA Approval for Weight Loss and Cardiovascular Risk Reduction Ajaz Yasmeen MD, FRCP, FACE posted on the topic LinkedIn

Store: www.parrocchiaolginate.it · Domain: www.parrocchiaolginate.it